Dengue Clinical Trials

155 clinical trials for Dengue across international registries, including 15 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Phase 1 Challenge Study Using rDEN2delta30-7169 to Evaluate Host-Pathogen Interactions in Primary, Homotypic, and Heterotypic Dengue Virus Infection — RECRUITING · PHASE1
• Gut Leakage' in Dengue — RECRUITING
• Butantan-DV Vaccine in Elderly Populations (DEN-04-IB) — RECRUITING · PHASE3
• A Study to Assess the Efficacy, Safety and Pharmacokinetics of EYU688 in Patients With Dengue Fever — RECRUITING · PHASE2
• A Study of CP-COV03 Compared With Placebo in Participants With Dengue (Part 1) and Dengue-like Illness (Part 2) — RECRUITING · PHASE2
• Adaptive Dengue Antiviral Platform Trial — RECRUITING · PHASE2
• A Controlled Human Infection Model of Dengue — RECRUITING · NA
• Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective — RECRUITING
• Risk Factors for Hospitalization and Transfusion Criteria in Patients With Dengue Virus Infection — RECRUITING
• Immune Responses to Dengue and Sepsis — RECRUITING
• Efficacy of Montelukast in Preventing Transaminase Elevation in Adult Dengue Patients — RECRUITING · PHASE2
• The Munich Dengue Cohort Study: Characterization of symptomatic and asymptomatic infections with Dengue viruses in Dengue fever patients and their travel companions — RECRUITING
• Impact of IIT-SIT on Dengue Clusters — RECRUITING · NA
• Dengue Vaccine Strategy in Children Aged 9 to 17 Years in the French Caribbean — RECRUITING
• A PHASE 2, RANDOMIZED, DOUBLE-BLIND, MULTICENTER STUDY TO EVALUATE THE SAFETY AND IMMUNOGENICITY OF THREE DIFFERENT POTENCY LEVELS OF V181 (DENGUE QUADRIVALENT VACCINE RDENV¿30 [LIVE, ATTENUATED]) IN HEALTHY ADULTS — RECRUITING · PHASE2
• EcoHealth approach for dengue control — ACTIVE_NOT_RECRUITING
• Emetine for Viral Outbreaks (a.k.a. EVOLVE Antiviral Initiative) — NOT_YET_RECRUITING · PHASE2
• Trial to Evaluate the Immunogenicity and Safety of the Co-administration of Live Attenuated Dengue and Chikungunya Vaccines Compared to Separate Administration in Adults Aged 18 to 59 Years. — NOT_YET_RECRUITING · PHASE3
• Efficacy and Safety of Carica Papaya in Dengue Fever: A Randomised Clinical Trial — COMPLETED · PHASE3
• Effects Of A Rehabilitation Protocol On Muscle Strength, Muscle Fatigue And Postural Control In Post-Dengue And Chikungunya Patients — NOT_YET_RECRUITING · NA
• Improving Disease Prevention Strategies by Integrating Socio-spatial Characterization of Human Mobility — ACTIVE_NOT_RECRUITING
• Therapeutics for Moderate and Severe Dengue — NOT_YET_RECRUITING · PHASE3
• Demographic Characteristics of TAK-003 Dengue Vaccine Recipients in Vietnam — ACTIVE_NOT_RECRUITING
• Using Digital Technology for the Prevention of Aedes-Borne Diseases in Colombian Communities — COMPLETED · NA
• Testing Combined IIT-SIT to Control Mosquito-Borne Diseases At Scale — TERMINATED · NA
• Characterizing Humoral Immune Response to Mosquito Bites — COMPLETED · NA
• Immunogenicity of an Intradermal Qdenga Vaccine Among Healthy Volunteers — COMPLETED · PHASE1
• Anakinra in Dengue With Hyperinflammation ( AnaDen ) — ACTIVE_NOT_RECRUITING · PHASE2
• Pilot Study to Detect DENGUE Virus in Sperm — COMPLETED · NA
• Clinical Bridging Study Between V181 (Dengue Quadrivalent Vaccine rDENVΔ30 [Live, Attenuated]) to Butantan Dengue Vaccine (Butantan - DV) in Healthy Adults 18 to 50 Years of Age in Brazil (V181 - 002) — COMPLETED · PHASE2
• Study to Examine the Effects of Oral Fenretinide — COMPLETED · PHASE2
• Dengue - Sample Collection Study Pakistan — NOT_YET_RECRUITING
• Quantifying the Epidemiological Impact of Targeted Indoor Residual Spraying on Aedes-borne Diseases — COMPLETED · NA
• Evaluation of T-cell Responses After Vaccination With the Attenuated Tetravalent Dengue Vaccine (Takeda). — ACTIVE_NOT_RECRUITING
• A Study of JNJ-64281802 for the Prevention of Dengue Infection — TERMINATED · PHASE2
• Effectiveness Evaluation of the "Mosquito-Free Campus" Initiative on Dengue Fever Prevention and Control: A Cluster Randomized Controlled Trial — NOT_YET_RECRUITING · NA
• Impact of Project Wolbachia - Singapore on Dengue Incidence — COMPLETED · NA
• An Evaluation of Repeated Oral Doses of JNJ-64281802 Against DENV-3 Challenge — COMPLETED · PHASE2
• Dengue 4 Human Infection Model (Dengue CVD 11000; DHIM-4) — COMPLETED · PHASE1
• Safety, Virological and Immunological Assessment of the Controlled Dengue Human Infection Model in Dengue-Immune Participants in Thailand (DHIT-Immune) — NOT_YET_RECRUITING · PHASE1
• ADVP005; Dengue CVD 12000 - Dengue-1-Virus Live Virus Human Challenge (DENV-1-LVHC) — COMPLETED · PHASE1
• Impact of Differential and Systematic Diagnosis of Dengue, Chikungunya and Malaria on Patient Management and Antibiotic Use in West Africa — COMPLETED · NA
• Safety and Immunogenicity of the Dengue Virus Vaccine TV005 (TetraVax-DV TV005) in Healthy Adults, Adolescents, and Children in Dhaka, Bangladesh — COMPLETED · PHASE2
• Homologous Re-infection With Dengue 1 or Dengue 3 — COMPLETED · PHASE1
• Citizen Action for Sustainable Dengue Control in Sub-Saharan Africa — COMPLETED · NA
• Dengue Controlled Human Infection Model in Dhaka, Bangladesh — ACTIVE_NOT_RECRUITING · PHASE2
• Virological and Immunological Determinants of Arbovirus Infection in New Caledonia — OTHER · NA
• Genetic Evolution of Arboviruses in New Caledonia Between 1995 and 2024 and Impact of Wolbachia — OTHER
• Population Immunity AgaiNst mosquitO-borne Diseases in Vanuatu — COMPLETED · NA
• Sustainable Reduction of Dengue in Colombia: Vector Breeding Site Intervention With an Insecticidal Coating — COMPLETED · NA

Refine this search